François Lang
Affiliations: | Université de Nantes. Unité de Formation et de Recherche de Médecine et des Techniques Médicales |
Google:
"François Lang"Children
Sign in to add trainee
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Charpentier M, Dupré E, Fortun A, et al. (2021) hnRNP-A1 binds to the IRES of MELOE-1 antigen to promote its translation in stressed melanoma cells. Molecular Oncology |
Dréno B, Khammari A, Fortun A, et al. (2021) Phase I/II clinical trial of adoptive cell transfer of sorted specific T cells for metastatic melanoma patients. Cancer Immunology, Immunotherapy : Cii |
Rabu C, Rangan L, Florenceau L, et al. (2019) Cancer vaccines: designing artificial synthetic long peptides to improve presentation of class I and class II T cell epitopes by dendritic cells. Oncoimmunology. 8: e1560919 |
Simon S, Wu Z, Cruard J, et al. (2018) TCR Analyses of Two Vast and Shared Melanoma Antigen-Specific T Cell Repertoires: Common and Specific Features. Frontiers in Immunology. 9: 1962 |
Simon S, Vignard V, Varey E, et al. (2017) Emergence of High-Avidity Melan-A-Specific Clonotypes as a Reflection of Anti-PD-1 Clinical Efficacy. Cancer Research. 77: 7083-7093 |
Charpentier M, Croyal M, Carbonnelle D, et al. (2016) IRES-dependent translation of the long non coding RNA meloe in melanoma cells produces the most immunogenic MELOE antigens. Oncotarget |
Simon S, Vignard V, Florenceau L, et al. (2016) PD-1 expression conditions T cell avidity within an antigen-specific repertoire. Oncoimmunology. 5: e1104448 |
Allard M, Oger R, Benlalam H, et al. (2014) Soluble HLA-I/peptide monomers mediate antigen-specific CD8 T cell activation through passive peptide exchange with cell-bound HLA-I molecules Journal of Immunology. 192: 5090-5097 |
Labarriere N, Fortun A, Bellec A, et al. (2013) A full GMP process to select and amplify epitope-specific T lymphocytes for adoptive immunotherapy of metastatic melanoma. Clinical & Developmental Immunology. 2013: 932318 |
Bobinet M, Vignard V, Florenceau L, et al. (2013) Overexpression of meloe gene in melanomas is controlled both by specific transcription factors and hypomethylation. Plos One. 8: e75421 |